OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10606	Companies
225110	Keywords
153806	Articles
119118	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 5 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 5 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 4 obligations convertibles en Oxurion pour une augmentation de capital de 100 000 EUR, soutenant le développement de médicaments pour préserver la vision des personnes âgées

Obligations Convertibles Augmentation De Capital Atlas Special Opportunities Médicaments Innovants Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 5 months ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 5 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold

Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF

published on 01/03/2025 at 18:05, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF

published on 01/03/2025 at 18:05, 1 year 5 months ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 5 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities

Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 5 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details

Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies

Accesswire

Published on 06/22/2026 at 11:00, 16 minutes ago

American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
Published on 06/22/2026 at 09:01, 2 hours 15 minutes ago

Apex Drills 14.9 m of 5.09 % REO and 12.3 m of 5.63 % REO with > 2.50 % REO Intercept Over 191.9 m in the Trinity Zone at the Rift Rare Earth Project
Published on 06/22/2026 at 03:00, 8 hours 16 minutes ago

Tunkillia Pre-Feasibility Study Begins
Published on 06/20/2026 at 01:00, 2 days 10 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 11 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 11:05, 11 minutes ago

Hisense Showcases "Innovating a Brighter Life" Message at FIFA World Cup 2026™
Published on 06/22/2026 at 11:02, 13 minutes ago

Siltronic returns to the MDAX
Published on 06/22/2026 at 11:00, 16 minutes ago

Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Published on 06/22/2026 at 10:55, 21 minutes ago

Envision Energy Unveils 2026 Net Zero Action Report at VivaTech, Pioneering Future Energy Systems for Civilizational Prosperity
Published on 06/22/2026 at 10:30, 46 minutes ago

Giotto.ai and KPS AG join forces to bring Giotto.ai’s breakthrough, sovereign and portable technology to European enterprise clients

Les Echos

Published on 06/22/2026 at 08:30, 2 hours 46 minutes ago

Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 2 hours 46 minutes ago

Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 15 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 15 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 15 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

View all LES ECHOS COMFI WIRE